Michel Dy Selected Research

Michel Dy Research Topics

Disease

7	Inflammation (Inflammations) 04/2016 - 08/2003
6	Neoplasms (Cancer) 09/2010 - 02/2003
5	Asthma (Bronchial Asthma) 07/2011 - 08/2003
3	Infections 01/2017 - 06/2009
3	Eosinophilia 12/2008 - 08/2003
2	Bone Resorption 04/2016 - 04/2009
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2015 - 09/2013
2	Autoimmune Diseases (Autoimmune Disease) 06/2013 - 09/2008
2	Hypersensitivity (Allergy) 01/2013 - 10/2007
2	Malaria 10/2011 - 06/2009
2	Cerebral Malaria 10/2011 - 06/2009
2	Colonic Neoplasms (Colon Cancer) 04/2004 - 04/2003
1	Human Influenza (Influenza) 01/2017
1	Experimental Arthritis 04/2016
1	Arthritis (Polyarthritis) 04/2016
1	Leukemia 06/2014
1	Psoriasis (Pustulosis Palmaris et Plantaris) 06/2014
1	Parasitic Diseases (Parasitic Disease) 06/2013
1	Hypothermia 01/2013
1	Anaphylaxis (Anaphylactic Shock) 01/2013
1	Immune System Diseases (Immune Disorders) 01/2010
1	Encephalomyelitis (Myeloencephalitis) 06/2009
1	Hepatitis 05/2007
1	Systemic Mastocytosis 08/2006
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 08/2006
1	Hematologic Neoplasms (Hematological Malignancy) 08/2006
1	Acquired Immunodeficiency Syndrome (AIDS) 09/2005
1	Carcinoma (Carcinomatosis) 04/2004
1	Pleural Effusion (Pleural Effusions) 04/2003

Drug/Important Bio-Agent (IBA)

7	Histamine (Histamine Dihydrochloride)FDA Link 01/2017 - 10/2007
7	CytokinesIBA 07/2011 - 04/2003
6	AllergensIBA 01/2013 - 08/2003
5	Immunoglobulin E (IgE)IBA 01/2013 - 08/2003
4	Interleukin-4 (Interleukin 4)IBA 05/2007 - 08/2003
3	Interleukin-5 (Interleukin 5)IBA 10/2005 - 08/2003
2	Interleukin-10 (Interleukin 10)IBA 07/2011 - 04/2004
2	LigandsIBA 07/2011 - 01/2011
2	resiquimodIBA 07/2011 - 01/2011
2	Interleukin-12 (IL 12)IBA 01/2011 - 05/2007
2	Interleukin-6 (Interleukin 6)IBA 09/2010 - 04/2004
2	Histamine Receptors (Histamine Receptor)IBA 04/2009 - 08/2008
2	Phosphotransferases (Kinase)IBA 08/2006 - 02/2003
2	TNF-Related Apoptosis-Inducing LigandIBA 09/2005 - 04/2003
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2004 - 04/2003
1	Interferon Type IIBA 01/2017
1	Serotonin (5 Hydroxytryptamine)IBA 04/2016
1	Interleukin-17 (Interleukin 17)IBA 04/2016
1	Histidine DecarboxylaseIBA 01/2015
1	Imiquimod (Aldara)FDA LinkGeneric 06/2014
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 06/2014
1	Transcription Factors (Transcription Factor)IBA 06/2014
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 09/2013
1	Complement System Proteins (Complement)IBA 06/2013
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2013
1	dinitrophenyl-human serum albumin conjugateIBA 01/2013
1	Antiviral Agents (Antivirals)IBA 01/2011
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 09/2010
1	Immunoglobulins (Immunoglobulin)IBA 09/2010
1	Interleukin-3 (Interleukin 3)IBA 09/2010
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2010
1	Biogenic Amines (Biogenic Amine)IBA 06/2009
1	tele-methylhistamineIBA 06/2009
1	gingerolIBA 12/2008
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 08/2008
1	Concanavalin AIBA 05/2007
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 08/2006
1	Sirolimus (Rapamycin)FDA Link 08/2006
1	alpha-galactosylceramideIBA 10/2005
1	AntibodiesIBA 10/2005
1	Interleukin-13IBA 02/2004
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 04/2003
1	DeoxyuridineIBA 04/2003
1	Annexin A5IBA 04/2003
1	Conditioned Culture MediaIBA 04/2003
1	Fas Ligand Protein (Fas Ligand)IBA 04/2003
1	Death Domain ReceptorsIBA 04/2003
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 04/2003
1	Imatinib Mesylate (Gleevec)FDA Link 02/2003
1	Tyrosine Kinase InhibitorsIBA 02/2003

Therapy/Procedure

1	Cell- and Tissue-Based Therapy (Cell Therapy) 06/2013
1	Stem Cell Transplantation 06/2013
1	Therapeutics 06/2009
1	Transplantation 09/2008
1	Immunotherapy 10/2004